May 29, 2026 · Science & Research Daily Digest
Science, space, biotech, and climate research highlights for May 29, 2026, with summaries, links, and commentary.
I. Space & Deep Space
1. Blue Origin New Glenn destroyed in static-fire test; LC-36 pad damage clouds Artemis and Moon Base schedules
Summary:
SpaceNews, the Associated Press, and other outlets report that Blue Origin’s heavy-lift New Glenn rocket exploded on May 28, 2026, at about 9 p.m. Eastern during a first-stage static-fire test at Launch Complex 36, Cape Canaveral Space Force Station, Florida. Videos show a massive fireball shortly after ignition of seven BE-4 engines; a lightning tower collapsed and pad infrastructure is expected to be heavily damaged. Blue Origin and Space Launch Delta 45 confirmed no injuries. The vehicle was being prepared for the NG-4 mission to deploy roughly 48 Amazon Leo broadband satellites, with a launch window once targeted for early June. New Glenn is also slated to launch Blue Moon landers for NASA’s Artemis and Moon Base programs. NASA Administrator Jared Isaacman said on May 29 that the agency will support a thorough investigation and assess impacts on Artemis and Moon Base as information becomes available.
Links:
- SpaceNews — New Glenn rocket explodes on Cape Canaveral pad
- WCTV / AP — Blue Origin rocket explodes on the launch pad during an engine-firing test
Commentary:
Less than six weeks after an NG-3 upper-stage failure stranded a payload, losing a full vehicle on the pad raises systemic questions about commercial heavy-lift reliability and lunar logistics redundancy.
II. Biomedicine & Health
2. GSK/Ionis hepatitis B drug bepirovirsen: ~20% “functional cure” in Phase 3, NEJM publication
Summary:
ScienceAlert and the Associated Press reported on May 29, 2026, that bepirovirsen—an antisense oligonucleotide from GSK and Ionis—achieved a functional cure (sustained undetectable virus six months after stopping all therapy) in about 20% of ~1,838 chronic hepatitis B patients across two international Phase 3 trials, versus none on placebo. Functional cure reached ~26% in patients with lower baseline HBsAg. Findings were presented in Barcelona and published in the New England Journal of Medicine. The FDA accepted the NDA for priority review with a PDUFA goal date of October 26, 2026. Experts caution that durability and applicability to cirrhosis and other complex populations still need longer follow-up.
Links:
- ScienceAlert — New Drug Offers 'Functional Cure' For Dangerous Liver Virus
- Fierce Biotech — GSK's hepatitis B drug cures one-fifth of patients in 'major step'
Commentary:
With more than 240 million people living with chronic HBV worldwide, freeing roughly one in five from lifelong therapy would reshape liver-disease epidemiology—if remission proves durable in real-world use.
3. China NMPA approves three Class 1 innovative drugs in one batch: CLI gene therapy, URAT1 gout drug, HER2+ gastric bispecific
Summary:
Per NMPA announcements and domestic coverage on May 29, 2026, three Class 1 drugs were approved on May 28: Norland’s sedormin plasmid gene therapy (Huasuoling) for critical limb ischemia ulcers—first and only domestic CLI drug, with 43.5% vs 18.5% ulcer healing and 1.9% vs 8.8% amputation at 180 days in Phase 3 HOPE-CLTI-2; Hengrui’s luzurorenat sodium (Ruiming), the first domestic URAT1 inhibitor for gout with hyperuricemia; and Shanghai Jinmate’s anituximab (Ennitux, KN026) plus chemotherapy for HER2-positive advanced gastric/GEJ cancer after prior anti-HER2 regimens, via priority review. The batch spans vascular gene therapy, metabolic small molecules, and oncology biologics.
Links:
- Sina Finance — Norland gene therapy approval (Chinese)
- NetEase — Three major domestic innovative drugs approved (Chinese)
Commentary:
Three first-in-class approvals on one day signal simultaneous commercialization across gene therapy, chronic metabolic disease, and post-line oncology in China’s innovative-drug pipeline.
III. Climate, Energy & Environment
4. Nature Communications: warming shifts global flood timing earlier; >50% of land sees >7-day shifts at 1.5°C
Summary:
Qi, Liu, Jiang, et al. (Nature Communications, published online May 29, 2026) used multi-model ensembles from 1.5°C to 4.0°C warming to assess changes in flood timing. Anthropogenic forcing advances global flood timing by ~0.43±0.25 days per 0.5°C warming, with regional divergence (early-flood regions earlier, late-flood regions delayed). At 1.5°C, ~50.73±4.23% of global land area faces timing shifts greater than seven days, rising to ~52.85±3.20% at 2.0°C. China, India, and the United States may see greater population exposure. The authors urge treating flood timing as a core variable in adaptation planning, not only magnitude and frequency.
Links:
Commentary:
Quantifying when floods occur—not just how large—maps climate risk directly onto reservoir operations, planting calendars, and insurance design.
5. Arctic sea-ice loss may have triggered a nitrate “tipping point,” threatening food webs and carbon uptake
Summary:
ScienceDaily highlights work in Communications Earth & Environment led by the University of Edinburgh: rapid Arctic sea-ice decline intensifies benthic denitrification on shelves, stripping nitrate essential for plankton. The team argues the Arctic Ocean ecosystem crossed a nitrogen-biogeochemistry regime shift around 2009, tied to ice loss and unlikely to revert. Impacts may cascade through fish, seabirds, and marine mammals and weaken carbon uptake; lead author Raja Ganeshram urges close monitoring of links to North Atlantic fisheries.
Links:
- ScienceDaily — Arctic Ocean passed a tipping point and scientists say it may never recover
- Communications Earth & Environment — Sea ice loss drives a regime shift in Arctic Ocean nitrogen biogeochemistry
Commentary:
The Arctic is not only an ice-extent chart but a nutrient-cycle hinge; tipping-point language implies narrowing adaptation windows rather than linear delay.
6. Korea–US team reports atomic platinum clusters in Science: ~90% less Pt, aimed at liquid organic hydrogen carriers
Summary:
South Korea’s Ministry of Science and ICT and The Korea Times reported on May 29, 2026, that a Seoul National University–Stanford team (Park Jung-won, Thomas F. Jaramillo, Matteo Cargnello, et al.) published in Science a ligand-stripped ~1 nm platinum cluster catalyst using roughly one-tenth the platinum of commercial catalysts while improving hydrogen output and durability for liquid organic hydrogen carrier (LOHC) routes. The team showed clusters of nearly identical size can contain 13–31 atoms, with atom count—not particle size alone—governing performance; lab batches of tens of grams per run suggest a path toward scale-up.
Links:
Commentary:
Atomic-level platinum control offers a measurable materials lever for green hydrogen costs while LOHC logistics mature.
7. POSTECH sunlight-driven graphene nanochannels boost lithium enrichment from brine up to ~28-fold
Summary:
DongA Science reported on May 29, 2026, that Sangjun Lee’s POSTECH team published in Advanced Functional Materials a nanofiltration membrane combining graphene nanoribbons and photothermal reduced graphene oxide. Powered only by solar interfacial evaporation, it selectively concentrates lithium from magnesium-rich brine without external electricity, large chemical loads, or evaporation ponds—up to ~28× enrichment under standard illumination. Simulations show low barriers for Li⁺ and blocked pathways for Mg²⁺ due to stronger Mg hydration shells.
Links:
Commentary:
Moving lithium recovery from geographically locked evaporation ponds toward deployable solar membrane units could reshape EV and storage supply-chain geography if field trials succeed.
IV. Fundamental Research, Chemistry & Origins of Life
8. Nature Communications: directed trilithiation yields entropy-stabilized Sb/Bi/Sn/Pb-centered triangulenes
Summary:
Gotoh, Nakatsuka, Kinoshita, et al. (Nature Communications, May 29, 2026) used regioselective trilithiation of nitrogen-bridged macrocycles to embed antimony, bismuth, tin, and lead into triangulene frameworks. Single-crystal X-ray shows deep bowl geometries and 1D columnar assemblies; despite strained bonding, compounds show strong thermal and chemical stability from rigid confinement. Antimony triangulenes undergo reversible trivalent/pentavalent redox. The authors present a general platform for heavy-atom embedding in curved π systems.
Links:
Commentary:
Main-group supramolecular chemistry is shifting from “can we make it?” to tuning oxidation states and assembly inside curved frameworks for functional materials.
9. Nature Communications: de novo lipid bilayers and protocell-like compartments without pre-existing membranes
Summary:
Khanal, Fracassi, Harjung, et al. (Nature Communications, online May 28, 2026) show soluble enzymes can build lipid tails from acetate and cysteine and spontaneously form diacyl lipids and vesicles with no pre-existing membranes, membrane proteins, or lipid templates. Pore-forming peptides transport precursors into vesicles for continuous lipid generation; glycolipid compartments maintain proton gradients—offering a route past the membrane-heredity paradox linking synthesis to compartment function.
Links:
Commentary:
If membranes and metabolism can co-emerge in one chemical network, origin-of-life models need less linear “vesicles first, enzymes later” storytelling.
10. Nature: cross-species transcriptomes reveal conserved modular hallmarks of mammalian ageing and mortality
Summary:
A Nature integrative study of >11,000 transcriptomes across >25 tissues in mouse, rat, macaque, and human builds interpretable age and mortality biomarkers that predict lifespan interventions, time to death, chronic disease, and rejuvenation signals. Ageing-related changes are conserved across species and cell types (e.g., CDKN1A, LGALS3), with protein levels linked to UK Biobank mortality and multimorbidity. Modular clocks separate inflammatory, interferon, mitochondrial, and other pathways; diseases, caloric restriction, and Klotho deficiency accelerate distinct modules—framing a cross-species architecture for targeting cellular subsystems.
Links:
Commentary:
Ageing biology gains a modular transcriptomic grammar beyond single epigenetic clocks—useful for designing combination-intervention trial endpoints.
Today's Summary
- Space: Blue Origin’s New Glenn pad explosion dominates headlines, threatening Amazon Leo, Artemis, and newly outlined Moon Base lunar cargo timelines.
- Biomedicine: bepirovirsen’s ~20% functional-cure data and a trio of Chinese Class 1 approvals mark parallel milestones in infectious-disease remission and domestic commercialization.
- Climate & energy: flood-timing shifts under warming and a possible Arctic nitrate tipping point contrast with green-hydrogen catalyst and solar lithium-recovery advances.
- Basic science: heavy-atom triangulenes, template-free protocell membranes, and modular mammalian ageing signatures advance materials, origins, and geroscience on the same day.
Daily Framing:
Today in the science cycle is a “heavy rocket setback, infection cure data, and climate–materials crosscurrents” day—engineering reliability crises, clinical endpoints, and Earth-system feedback compete for policy and capital attention.
This digest is compiled from live search results for reference only; verify facts against primary sources.
Date: May 29, 2026 (Friday)